GENSIGHT BIOLOGICS S.A. (EPA:SIGHT)

PRESS RELEASE

published on 09/27/2024 at 11:24, 6 months 28 days ago

HALF-YEAR_FINANCIAL_REPORT_JUNE_2024
BRIEF

published on 09/23/2024 at 19:41, 7 months 2 days ago

GenSight Biologics Reports Interim Financial Results for H1 2024

Financial Results Cash Management LUMEVOQ® Early Access Program R&D Expenses
PRESS RELEASE

published on 09/23/2024 at 19:36, 7 months 2 days ago

Inside Information / News release on accounts, results
GenSight Biologics reports interim financial results for the first half of 2024, highlighting optimized cash management, extension of cash runway, and upcoming LUMEVOQ® drug product release

Cash Management GenSight Biologics Interim Financial Results LUMEVOQ® Drug Product Release
BRIEF

published on 09/17/2024 at 14:45, 7 months 8 days ago

Goldman Sachs sells its GENSIGHT BIOLOGICS SA shares

Euronext Paris Goldman Sachs Crossing Thresholds Transfer Of Shares GenSight Biologics
BRIEF

published on 07/23/2024 at 07:35, 9 months 2 days ago

GenSight Biologics Reports Financial Position and Business Progress

Gene Therapy Financial Update GenSight Biologics LUMEVOQ Early Access Program
PRESS RELEASE

published on 07/23/2024 at 07:30, 9 months 2 days ago

Inside Information / News release on accounts, results
GenSight Biologics reports cash position of €6.9 million as of June 30, 2024, with potential over 100 vials available upon Q3 resumption of early access program. Company confirms sufficient working capital and successful blending step for LUMEVOQ drug product

Working Capital Business Update Cash Position GenSight Biologics LUMEVOQ Drug Product
BRIEF

published on 07/11/2024 at 07:35, 9 months 14 days ago

GenSight Biologics Launches Newsletter for Retail Investors

Financial Updates Gene Therapy Retail Investors LUMEVOQ® Optogenetics
PRESS RELEASE

published on 07/11/2024 at 07:30, 9 months 14 days ago

Inside Information / Other news releases
GenSight Biologics launches a newsletter for retail investors providing updates, news articles, conferences, and financial figures in French, available via subscription on the company's website

Subscription Retail Investors Newsletter French GenSight Biologics
BRIEF

published on 06/20/2024 at 07:35, 10 months 5 days ago

GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates

Gene Therapy Operational Update GenSight Biologics Financial Negotiation
PRESS RELEASE

published on 06/20/2024 at 07:30, 10 months 5 days ago

Inside Information / Other news releases
GenSight Biologics renegotiates financial obligations and provides operational updates, with successful capital increases enhancing short-term flexibility

Financial Obligations Operational Updates GenSight Biologics Capital Increases Gene Therapies

Published on 04/25/2025 at 18:45, 1 hour 33 minutes ago

New to The Street Airs on Bloomberg TV Saturday, April 26 at 6:30 PM ET Featuring BioVie (NASDAQ: BIVI), Skip Barber Racing School with CFO Michael Berg, CommercialVille.tv, Sustainable Green Team (OTCPK: SGTM) WaterLess Garden, and The Business of Blockc
Published on 04/25/2025 at 16:25, 3 hours 53 minutes ago

AXCAP Announces Automatic Conversion of Special Warrants
Published on 04/25/2025 at 16:00, 4 hours 18 minutes ago

Southern ITS International, Inc., DBA CorpHQ; Pure Oil & Gas Acquires Multiple Oil & Gas Assets in Jones County, Texas; Partners with Last Mile Production LLC to Drive Production Through Advanced Technology
Published on 04/25/2025 at 15:00, 5 hours 18 minutes ago

Route1 Announces Details of The Release of Its Fiscal Year 2024 Results
Published on 04/25/2025 at 14:00, 6 hours 18 minutes ago

Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)

View all ACCESSWIRE

Published on 04/25/2025 at 18:44, 1 hour 34 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 04/25/2025 at 18:31, 1 hour 46 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/25/2025 at 18:30, 1 hour 48 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/25/2025 at 18:30, 1 hour 48 minutes ago

Holding(s) in Company
Published on 04/25/2025 at 18:00, 2 hours 17 minutes ago

Annual General Meeting of Arbonia AG approves all motions

View all EQS

Published on 04/25/2025 at 18:16, 2 hours 2 minutes ago

PR_Carrefour Brazil_25042025
Published on 04/25/2025 at 18:05, 2 hours 13 minutes ago

Louis Hachette Group - 2025 First-quarter revenue
Published on 04/25/2025 at 18:00, 2 hours 18 minutes ago

Availability of the 2024 universal registration document
Published on 04/25/2025 at 18:00, 2 hours 18 minutes ago

Postponement of the publication of the annual financial statements
Published on 04/25/2025 at 17:45, 2 hours 33 minutes ago

LANSON-BCC: GENERAL SHAREHOLDERS’ MEETING ON APRIL 25, 2025 - DIVIDEND: €0.90 PER SHARE

View all LES ECHOS COMFI WIRE

News